Vor Biopharma Inc.
VOR- 交易所
- Nasdaq
- 產業
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817229
近 90 天,Vor Biopharma Inc. 沒有內部人公開市場買賣的申報;2026 年第 3 季末有 155 家機構在 13F 申報持有,市值合計 $10.6 億;沒有大師持有。
SEC 申報
Vor Biopharma Inc. 向 SEC 申報的 10-K、10-Q、8-K、20-F、40-F,最新的在前。
Livermore 只列出每份申報的表單、8-K 的 Item 與日期。內文請到 SEC 網站讀;8-K 的新聞稿等附件(例如 Item 2.02 的 EX-99.1)在申報目錄裡。
| 申報日 | 表單 | 8-K 的 Item | 期間 | 原文 | 申報目錄 |
|---|---|---|---|---|---|
| 2026/11/12 | 8-K | 1.013.027.019.01 | 2026/11/11 | SEC | 目錄 |
| 2026/10/30 | 10-Q | – | 2026/9/30 | SEC | 目錄 |
| 2026/8/11 | 10-Q | – | 2026/6/30 | SEC | 目錄 |
| 2026/7/7 | 8-K | 5.029.01 | 2026/7/6 | SEC | 目錄 |
| 2026/6/12 | 8-K | 5.079.01 | 2026/6/11 | SEC | 目錄 |
| 2026/6/8 | 8-K | 7.019.01 | 2026/6/8 | SEC | 目錄 |
| 2026/5/13 | 10-Q | – | 2026/3/31 | SEC | 目錄 |
| 2026/3/30 | 10-K | – | 2025/12/31 | SEC | 目錄 |
| 2026/3/27 | 8-K | 1.013.027.019.01 | 2026/3/26 | SEC | 目錄 |
| 2026/1/12 | 8-K | 2.027.019.01 | 2026/1/12 | SEC | 目錄 |
| 2026/1/2 | 8-K | 5.02 | 2025/12/31 | SEC | 目錄 |
| 2025/12/18 | 8-K | 1.013.025.027.019.01 | 2025/12/15 | SEC | 目錄 |
| 2025/12/9 | 8-K | 5.02 | 2025/12/5 | SEC | 目錄 |
| 2025/11/13 | 10-Q | – | 2025/9/30 | SEC | 目錄 |
| 2025/11/12 | 8-K | 8.019.01 | 2025/11/10 | SEC | 目錄 |
| 2025/11/3 | 8-K | 5.027.019.01 | 2025/11/2 | SEC | 目錄 |
| 2025/10/28 | 8-K | 7.019.01 | 2025/10/28 | SEC | 目錄 |
| 2025/9/17 | 8-K | 3.038.019.01 | 2025/9/17 | SEC | 目錄 |
| 2025/9/2 | 8-K | 7.019.01 | 2025/9/2 | SEC | 目錄 |
| 2025/8/27 | 8-K | 5.02 | 2025/8/25 | SEC | 目錄 |
| 2025/8/27 | 8-K | 5.025.078.019.01 | 2025/8/25 | SEC | 目錄 |
| 2025/8/12 | 10-Q | – | 2025/6/30 | SEC | 目錄 |
| 2025/7/22 | 8-K | 5.027.019.01 | 2025/7/16 | SEC | 目錄 |
| 2025/7/10 | 8-K | 5.027.019.01 | 2025/7/9 | SEC | 目錄 |
| 2025/6/26 | 8-K | 1.011.023.025.027.019.01 | 2025/6/25 | SEC | 目錄 |
| 2025/5/23 | 8-K | 5.035.079.01 | 2025/5/22 | SEC | 目錄 |
| 2025/5/20 | 8-K | 5.02 | 2025/5/19 | SEC | 目錄 |
| 2025/5/14 | 10-Q | – | 2025/3/31 | SEC | 目錄 |
| 2025/5/8 | 8-K | 2.055.028.019.01 | 2025/5/5 | SEC | 目錄 |
| 2025/4/25 | 8-K | 3.01 | 2025/4/22 | SEC | 目錄 |
| 2025/4/3 | 8-K | 5.02 | 2025/3/31 | SEC | 目錄 |
| 2025/3/20 | 10-K | – | 2024/12/31 | SEC | 目錄 |
| 2025/2/6 | 8-K | 5.02 | 2025/2/3 | SEC | 目錄 |
| 2025/1/8 | 8-K | 5.027.019.01 | 2025/1/6 | SEC | 目錄 |
| 2024/12/27 | 8-K | 1.013.027.018.019.01 | 2024/12/26 | SEC | 目錄 |
| 2024/12/9 | 8-K | 7.018.019.01 | 2024/12/9 | SEC | 目錄 |
| 2024/11/7 | 10-Q | – | 2024/9/30 | SEC | 目錄 |
| 2024/9/30 | 8-K | 5.027.019.01 | 2024/9/30 | SEC | 目錄 |
| 2024/9/5 | 8-K | 7.018.019.01 | 2024/9/5 | SEC | 目錄 |
| 2024/8/30 | 8-K | 3.01 | 2024/8/29 | SEC | 目錄 |
| 2024/8/8 | 10-Q/A | – | 2024/3/31 | SEC | 目錄 |
| 2024/8/8 | 10-Q | – | 2024/6/30 | SEC | 目錄 |
| 2024/6/10 | 8-K | 5.02 | 2024/6/4 | SEC | 目錄 |
| 2024/5/28 | 8-K | 5.025.079.01 | 2024/5/23 | SEC | 目錄 |
| 2024/5/9 | 10-Q | – | 2024/3/31 | SEC | 目錄 |
| 2024/5/2 | 8-K | 5.027.019.01 | 2024/4/30 | SEC | 目錄 |
| 2024/3/20 | 10-K | – | 2023/12/31 | SEC | 目錄 |
| 2024/1/5 | 8-K | 8.019.01 | 2024/1/5 | SEC | 目錄 |
| 2023/11/7 | 10-Q | – | 2023/9/30 | SEC | 目錄 |
| 2023/11/2 | 8-K | 7.018.019.01 | 2023/11/2 | SEC | 目錄 |